Abstract
Reverse phase protein array (RPPA) provides investigators with a powerful high-throughput, quantitative, cost-effective technology for functional proteomics studies. It is an antibody-based technique with procedures similar to that of Western blots. RPPA has a wide variety of applications that range from pharmacodynamics and drug sensitivity assessment to biomarker discovery, subtype classification, and prediction of patient prognosis and response to targeted therapy. In this paper, we describe the technology, its limitations, and some solutions to overcome them. We discuss the steps necessary to obtain raw RPPA data and convert them into robust, high-quality, analysis-ready data. We then illustrate the utility of the platform by highlighting some biomarkers and drug responses of cancer cell lines that confirm previous findings, as a means to validate the platform and the methods presented here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akbani R et al (2014) A pan-cancer proteomic perspective on the Cancer genome atlas. Nat Commun 5(5):3887
Burris HA (2004) Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 9(Suppl 3):10–15
Gespach C (2011) Increasing potential of HER3 signaling in Colon Cancer progression and therapy. Clin Cancer Res AACR 18(4):1–3
Ghandi M et al (2019) Next-generation characterization of the Cancer cell line encyclopedia. Nature 569(7757):503–508
Hui J et al (2007) Non-parametric quantification of protein lysate arrays. Bioinformatics 23(15)
Ju Z et al (2015) Development of a robust classifier for quality control of reverse-phase protein arrays. Bioinformatics 31(6):912–918
Liu W et al (2014) A comprehensive comparison of normalization methods for loading control and variance stabilization of reverse phase protein Array (RPPA) data. Cancer Inform Libertas Acad 13:109–117
Mannsperger HA et al (2010) RPPanalyzer: analysis of reverse-phase protein array data. Bioinformatics 26(17):2202–2203
Neeley S et al (2009) Variable slope normalization of reverse phase protein arrays. Bioinformatics 25(11):1384–1389
Neeley S et al (2012) Surface adjustment of reverse phase protein arrays using positive control spots. Cancer Informat 11:77–86
Perou CM et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752
The Cancer Genome Atlas Network Nature (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70
Tsang VC et al (1985) Enzyme-linked immunoelectrotransfer blot (EITB). In: Ngo TT, Lenhoff HM (eds) Enzyme-mediated immunoassay. Plenum Press, New York, pp 389–414
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Akbani, R., Ling, S., Lu, Y. (2019). Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data. In: Yamada, T., Nishizuka, S., Mills, G., Liotta, L. (eds) Reverse Phase Protein Arrays. Advances in Experimental Medicine and Biology, vol 1188. Springer, Singapore. https://doi.org/10.1007/978-981-32-9755-5_9
Download citation
DOI: https://doi.org/10.1007/978-981-32-9755-5_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9754-8
Online ISBN: 978-981-32-9755-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)